RESOURCE CENTER

Woman wearing a lab coat in front of a microscope

Pharmaceuticals: Connect teams from research to remedy

Create efficiencies that reduce costs and unlock innovation

Today’s pharmaceutical companies are working to drive innovation, both within their organizations and in their interactions with customers and patients. This necessitates that they prioritize personalized engagement while at the same time maintaining focus on speeding up research and development efforts. This can be challenging, especially in the face of industry pressures such as drug pricing, reimbursement constraints, and the need to maximize efficiency.

A trusted, AI-powered, connected life sciences platform can help address these challenges. When systems, data, and processes are connected, pharmaceutical companies can take advantage of intelligent solutions that better equip them to manage the essential steps of bringing a drug to market: clinical trials, supply chain, marketing, sales, and patient services. And in the pharmaceutical business, that not only means an increase in efficiency and cost savings for the company, but also an improvement in adherence, personalized support, and most importantly patient outcomes.

AI enabled intelligent automation and advanced analytics have the potential to reduce process timeline up to 60% to 70% due to on-demand/near real-time intervention in clinical trials, supply optimization, and true data driven decision-making.

Source: Next in Pharma 2024: Reinventing for returns. PwC.

Technology solves pain points across the pharmaceutical industry by:

Creating more seamless connections between pharma companies, patients and healthcare providers

PAIN POINT

Pharma companies have a hard time directly engaging with patients, making it hard to understand how well therapies work in the real world.

ANTIDOTE

A connected, AI-powered life sciences platform brings everyone together creating more seamless connections between pharma companies, patients, and their healthcare providers. These connections enable pharma companies to get patients on therapies more quickly, ensure compliance, track therapy-specific programs, and make program improvements when necessary.

Connecting data to extract insights and create a better patient experience

PAIN POINT

Pharma companies have more patient data than ever before, but without a way to extract actionable insights, its value isn’t fully realized, nor can it be used to create better, more intelligent patient experiences.

ANTIDOTE

The ability to unify data from disparate sources — including clinical and real-world — creates a richer data set from which to learn about customers, analyze therapy adherence, and measure success. A connected, AI-powered life sciences platform has built-in automated processes and AI capabilities that can then act on this data to provide teams with more productive workflows as well as real-time insights directly in the flow of work. Ultimately this enables pharmaceutical companies to deliver more efficient, targeted, and personalized care.

Accelerating clinical trials

PAIN POINT

The costs of clinical trials are rising. Challenges with patient recruitment and retention result in lost market opportunity, longer time to market, and difficulties in achieving health equity.

ANTIDOTE

Bringing teams and data together on a single platform allows pharma companies to achieve greater transparency, efficiency, and collaboration. It makes it easier to recruit patients (including virtually), prevent attrition, identify and activate the right sites, and gain a complete view of the trial. This ability to share critical data securely between teams and ensure compliance at every stage ensures more success at every phase of clinical development.

Facilitating collaboration and support for advanced therapy delivery

PAIN POINT

Cell and gene therapy is the next frontier for pharmaceutical treatment due to its ability to greatly improve outcomes for rare diseases. However, the advanced collaboration required to develop and deliver these types of treatments can be difficult for companies to both facilitate and support.

ANTIDOTE

A connected, AI-powered life sciences platform can streamline and scale advanced therapy delivery, improving outcomes for patients while lowering costs for pharmaceutical companies. Data integration, automation, and AI enable pharmaceutical organizations to automate therapy organization at scale, support patient safety and compliance needs, and proactively identify bottlenecks and actionable next steps, in real-time. The platform provides an intelligent command center with the ability to reduce error, increase cost-savings, and maintain full visibility of custody chains and data.

Optimizing healthcare provider engagement

PAIN POINT

Building relationships with healthcare providers in a targeted, personalized manner can be difficult to do at scale.

ANTIDOTE

A centralized platform streamlines engagement with healthcare professionals (HCPs) through data driven experiences. A unified view enables pharmaceutical companies to understand important preferences and behaviors so that they can drive dynamic, personalized engagement that works to build better HCP relationships. A connected platform also streamlines medical inquiry management and enables self service, on demand.